and they 're pretty good of psych note , zyprexa sales were up compared to the st quarter of ' cymbalta sales up from q ' , and strattera sales down from q ' overall , sales were up source according to bloomberg , lilly is planning to ramp up marketing of cymbalta and zyprexa can you say viva zyprexa strikes back ? how about anxiety hurts , ? i wonder to whom lilly will market zyprexa ? seriously they 've tried primary care , psychiatrists , and likely the geriatric market , so who 's next ? how about pediatricians ? tantrum zyprexa ?